AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-83
Results: 1-25/83
AMINOSALICYLATES IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
Authors: SUTHERLAND LR
Citation: Lr. Sutherland, AMINOSALICYLATES IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE, Inflammatory bowel diseases, 4(2), 1998, pp. 113-113
INCREASED INTESTINAL PERMEABILITY IS ASSOCIATED WITH THE DEVELOPMENT OF MULTIPLE ORGAN DYSFUNCTION SYNDROME IN CRITICALLY ILL ICU PATIENTS
Authors: DOIG CJ SUTHERLAND LR SANDHAM JD FICK GH VERHOEF M MEDDINGS JB
Citation: Cj. Doig et al., INCREASED INTESTINAL PERMEABILITY IS ASSOCIATED WITH THE DEVELOPMENT OF MULTIPLE ORGAN DYSFUNCTION SYNDROME IN CRITICALLY ILL ICU PATIENTS, American journal of respiratory and critical care medicine, 158(2), 1998, pp. 444-451
THE CASE-AGAINST - THE CASE AGAINST ROUTINE POSTOPERATIVE THERAPY FORPREVENTION OF RECURRENCE IN CROHNS-DISEASE
Authors: BRESLIN NP SUTHERLAND LR
Citation: Np. Breslin et Lr. Sutherland, THE CASE-AGAINST - THE CASE AGAINST ROUTINE POSTOPERATIVE THERAPY FORPREVENTION OF RECURRENCE IN CROHNS-DISEASE, The Italian Journal of Gastroenterology, 30(2), 1998, pp. 226-230
MESALAZINE AS A MAINTENANCE TREATMENT IN CROHNS-DISEASE
Authors: SUTHERLAND LR STEINHART AH
Citation: Lr. Sutherland et Ah. Steinhart, MESALAZINE AS A MAINTENANCE TREATMENT IN CROHNS-DISEASE, Gut, 42(1), 1998, pp. 143-144
ORAL-CONTRACEPTIVE USE AND SMOKING ARE RISK-FACTORS FOR RELAPSE IN CROHNS-DISEASE
Authors: TIMMER A SUTHERLAND LR MARTIN F
Citation: A. Timmer et al., ORAL-CONTRACEPTIVE USE AND SMOKING ARE RISK-FACTORS FOR RELAPSE IN CROHNS-DISEASE, Gastroenterology, 114(6), 1998, pp. 1143-1150
ACCEPTANCE BY THE AGA IS THE SINGLE BEST INDICATOR OF SUBSEQUENT FULLPUBLICATION OF RESEARCH
Authors: TIMMER A COLE JH MACARTHUR C BRASHER P HAILEY D SUTHERLAND LR
Citation: A. Timmer et al., ACCEPTANCE BY THE AGA IS THE SINGLE BEST INDICATOR OF SUBSEQUENT FULLPUBLICATION OF RESEARCH, Gastroenterology, 114(4), 1998, pp. 185-185
IS THERE BIAS IN THE SELECTION OF ABSTRACTS FOR PRESENTATION AT THE DDW
Authors: TIMMER A MACARTHUR C HILSDEN RJ BRASHER P COLE JH HAILEY D SUTHERLAND LR
Citation: A. Timmer et al., IS THERE BIAS IN THE SELECTION OF ABSTRACTS FOR PRESENTATION AT THE DDW, Gastroenterology, 114(4), 1998, pp. 186-186
GASTRIC-CANCER AND OTHER ENDOSCOPIC FINDINGS IN YOUNG-PATIENTS WITH DYSPEPSIA
Authors: BRESLIN NP THOMSON ABR BAILEY RJ BLUSTEIN PK MEDDINGS J LALOR I VANROSENDAAL GMA VERHOEF MJ SUTHERLAND LR
Citation: Np. Breslin et al., GASTRIC-CANCER AND OTHER ENDOSCOPIC FINDINGS IN YOUNG-PATIENTS WITH DYSPEPSIA, Gastroenterology, 114(4), 1998, pp. 2332-2332
G3859 INTESTINAL PERMEABILITY IS ALTERED IN THE SPOUSES OF PATIENTS WITH CROHNS-DISEASE
Authors: BRESLIN NP PRICE LM HERSHFIELD NB NASH C MEDDINGS J SUTHERLAND LR
Citation: Np. Breslin et al., G3859 INTESTINAL PERMEABILITY IS ALTERED IN THE SPOUSES OF PATIENTS WITH CROHNS-DISEASE, Gastroenterology, 114(4), 1998, pp. 3859-3859
DOES MEDICAL ANTIREFLUX THERAPY IMPROVE ASTHMA IN ASTHMATICS WITH GASTROESOPHAGEAL REFLUX - A CRITICAL-REVIEW OF THE LITERATURE
Authors: FIELD SK SUTHERLAND LR
Citation: Sk. Field et Lr. Sutherland, DOES MEDICAL ANTIREFLUX THERAPY IMPROVE ASTHMA IN ASTHMATICS WITH GASTROESOPHAGEAL REFLUX - A CRITICAL-REVIEW OF THE LITERATURE, Chest, 114(1), 1998, pp. 275-283
STANDARDS FOR TRIALS OF THERAPY IN INFLAMMATORY BOWEL-DISEASE
Authors: SUTHERLAND LR HANAUER S SCHOLMERICH J
Citation: Lr. Sutherland et al., STANDARDS FOR TRIALS OF THERAPY IN INFLAMMATORY BOWEL-DISEASE, Inflammatory bowel diseases, 3(4), 1997, pp. 277-283
ALTERNATIVES TO SULFASALAZINE - A METAANALYSIS OF 5-ASA IN THE TREATMENT OF ULCERATIVE-COLITIS
Authors: SUTHERLAND LR ROTH DE BECK PL
Citation: Lr. Sutherland et al., ALTERNATIVES TO SULFASALAZINE - A METAANALYSIS OF 5-ASA IN THE TREATMENT OF ULCERATIVE-COLITIS, Inflammatory bowel diseases, 3(2), 1997, pp. 65-78
ENDOSCOPISTS OPINIONS OF INDICATIONS FOR UPPER GASTROINTESTINAL ENDOSCOPY
Authors: SUTHERLAND LR VERHOEF MJ MEDDINGS JB BAILEY RJ BLUSTEIN PB LALOR EA THOMSON ABR VANROSENDAAL GM
Citation: Lr. Sutherland et al., ENDOSCOPISTS OPINIONS OF INDICATIONS FOR UPPER GASTROINTESTINAL ENDOSCOPY, Canadian journal of gastroenterology, 11(3), 1997, pp. 221-227
MAINTENANCE THERAPY FOR INFLAMMATORY BOWEL-DISEASE - WHAT REALLY WORKS
Authors: SUTHERLAND LR
Citation: Lr. Sutherland, MAINTENANCE THERAPY FOR INFLAMMATORY BOWEL-DISEASE - WHAT REALLY WORKS, Canadian journal of gastroenterology, 11(3), 1997, pp. 261-264
REVIEW ARTICLE - TREATMENT OF CLOSTRIDIUM-DIFFICILE INFECTION
Authors: ZIMMERMAN MJ BAK A SUTHERLAND LR
Citation: Mj. Zimmerman et al., REVIEW ARTICLE - TREATMENT OF CLOSTRIDIUM-DIFFICILE INFECTION, Alimentary pharmacology & therapeutics, 11(6), 1997, pp. 1003-1012
METALLOPROTEINASES AND THEIR INHIBITORS IN CROHNS-DISEASE
Authors: MEDLICOTT SAC EDWARDS DR GWYN L KOSSAKOWSKA AE STABBLER A SUTHERLAND LR URBANSKI SJ
Citation: Sac. Medlicott et al., METALLOPROTEINASES AND THEIR INHIBITORS IN CROHNS-DISEASE, Laboratory investigation, 76(1), 1997, pp. 339-339
COULD ALTERNATIVE APPROACHES SUBSTITUTE FOR COLONOSCOPY IN THE INVESTIGATION OF PATIENTS WITH BRIGHT RED RECTAL BLEEDING [BRRB]
Authors: VANROSENDAAL GMA MEDDINGS JB BAILEY RJ BLUSTEIN PK LALOR EA THOMSON ABR VERHOEF MJ SUTHERLAND LR
Citation: Gma. Vanrosendaal et al., COULD ALTERNATIVE APPROACHES SUBSTITUTE FOR COLONOSCOPY IN THE INVESTIGATION OF PATIENTS WITH BRIGHT RED RECTAL BLEEDING [BRRB], Gastroenterology, 112(4), 1997, pp. 47-47
TREATMENT OF CLOSTRIDIUM-DIFFICILE DISEASE - A SYSTEMATIC REVIEW AND METAANALYSIS
Authors: ZIMMERMAN MJ BAK A SUTHERLAND LR
Citation: Mj. Zimmerman et al., TREATMENT OF CLOSTRIDIUM-DIFFICILE DISEASE - A SYSTEMATIC REVIEW AND METAANALYSIS, Gastroenterology, 112(4), 1997, pp. 50-50
SUCRALOSE - A NOVEL PERMEABILITY MARKER FOR COLONIC DISEASE
Authors: ENNS R BAK A MEDDINGS J SUTHERLAND LR
Citation: R. Enns et al., SUCRALOSE - A NOVEL PERMEABILITY MARKER FOR COLONIC DISEASE, Gastroenterology, 112(4), 1997, pp. 967-967
INCREASED PLASMA MMP-2 ACTIVITY AND REDUCED TIMP-2 ACTIVITY CHARACTERIZES CROHNS-DISEASE IN REMISSION
Authors: MEDLICOTT SAC EDWARDS DR KOSSAKOWSKA AE STABBLER A SUTHERLAND LR URBANSKI SJ
Citation: Sac. Medlicott et al., INCREASED PLASMA MMP-2 ACTIVITY AND REDUCED TIMP-2 ACTIVITY CHARACTERIZES CROHNS-DISEASE IN REMISSION, Gastroenterology, 112(4), 1997, pp. 1039-1039
DETERMINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) FOR COMMONLY USED ACTIVITY INDEXES IN CROHNS-DISEASE
Authors: SUTHERLAND LR BRIDGES R BRANT R HILSDEN R
Citation: Lr. Sutherland et al., DETERMINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) FOR COMMONLY USED ACTIVITY INDEXES IN CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 1100-1100
RISK-FACTORS FOR RECURRENCE IN QUIESCENT CROHNS-DISEASE (CD)
Authors: TIMMER A SUTHERLAND LR MARTIN F HILSDEN R
Citation: A. Timmer et al., RISK-FACTORS FOR RECURRENCE IN QUIESCENT CROHNS-DISEASE (CD), Gastroenterology, 112(4), 1997, pp. 1104-1104
INTESTINAL PERMEABILITY (IP) BEFORE AND AFTER IBUPROFEN IN FAMILIES OF CHILDREN WITH CROHNS-DISEASE
Authors: ZAMORA SA SCOTT RB BUTZNER DJ HILSDEN RJ MEDDINGS JB SUTHERLAND LR
Citation: Sa. Zamora et al., INTESTINAL PERMEABILITY (IP) BEFORE AND AFTER IBUPROFEN IN FAMILIES OF CHILDREN WITH CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 1127-1127
A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF MESALAMINE INTHE MAINTENANCE OF REMISSION OF CROHNS-DISEASE
Authors: SUTHERLAND LR MARTIN F BAILEY RJ FEDORAK RN POLESKI M DALLAIRE C ROSSMAN R SAIBIL F LARIVIERE L MEYER D BAKER SJ ALVI AW BASS S BLUSTEIN PK BRIDGES RJ LAY TE VANROSENDAAL GMA WATSON MH CLERMONT R COCKERAM AW MABEY M DACOSTA L BECK IT DEPEW W GROLL A PATERSON W SIMON J VANNER S DAMORE D SHERBANIUK R CHERRY R LALOR E THOMSON ABR YACYSHYN B BAIN V FISHER D KIRDEIKIS P HALLE P IRVINE EJ COLLINS SM CROITORU K CROWE SE GOODACRE RL HUNT RH SABENA BJ DONNELLY M KHAN MAR LANGEVIN S MENARD DB HADDAD H GOUPIL G LEMIRE S LAVOIE S PARENT C MERCILLE L MCHATTIE JD EDWARD J MILLAN MS MACIEJKO S MOUSSEAU R THIBERT F ARCHAMBAULT A AUMAIS G COTE S JOBIN G LACHANCE JR TROUVE ML MARCHAND J PAPP D HOLLAND SG BUYTENDORP M PARE P DUBE R LAFRANCE D LICHTER M COLLINS D RENDER KC BORTHISTLE BK NOVAK W PARCHOMCHUK K GUHA B COHEN L PEAREN S HERSHFIELD N MACCANNELL K MEDDINGS J PRICE L SHAFFER E RACICOT N WATIER A TRAVERSY L WHITTAKER JS AMAR J HALPARIN L STORDY SN WILD GE CLELAND D DALY DS FINKENBINE S WILLIAMS CN BOGIEWICK E WOLMAN SL COPNICK C WOROBETZ LJ OSACHOFF J WAY H
Citation: Lr. Sutherland et al., A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF MESALAMINE INTHE MAINTENANCE OF REMISSION OF CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 1069-1077
PULMONARY-FUNCTION ABNORMALITIES IN PATIENTS WITH ULCERATIVE-COLITIS
Authors: GODET PG COWIE R WOODMAN RC SUTHERLAND LR
Citation: Pg. Godet et al., PULMONARY-FUNCTION ABNORMALITIES IN PATIENTS WITH ULCERATIVE-COLITIS, The American journal of gastroenterology, 92(7), 1997, pp. 1154-1156
Risultati: 1-25 | 26-50 | 51-75 | 76-83